In principle, adaptation to CPAP is performed in the sleep laboratory by means of polysomnography with concomitant esophageal pressure recording. This practice is both expensive and responsible for long waiting lists. Moreover the effective CPAP level (Peff) remains a trade-off between pressure-related side effects and efficacy in preventing upper-airway obstruction during sleep. The Peff can change during a given night and from one night to another,
O
bstructive sleep apnea syndrome (OSAS) is an important health problem associated with increased morbidity and mortality due to cardiovascular and neuropsychological disorders, 1,2 as well as with an increased risk for motor vehicle accidents. 3 Nasal continuous positive airway pressure (CPAP), which was introduced in 1981 by Sullivan et al, 4 has considerably improved the treatment and prognosis of OSAS and remains the most effective treatment.
In principle, adaptation to CPAP is performed in the sleep laboratory by means of polysomnography with concomitant esophageal pressure recording. This practice is both expensive and responsible for long waiting lists. Moreover the effective CPAP level (Peff) remains a trade-off between pressure-related side effects and efficacy in preventing upper-airway obstruction during sleep. The Peff can change during a given night and from one night to another, This work has been funded by Institut National de la Santé et de la Recherche Mé dicale (INSERM, France), and was supported in part by Nellcor-Puritan Bennett. Manuscript received November 4, 1999 depending on body position, sleep stage, nasal patency, and other factors, such as ingestion of alcohol or hypnotic agents. [5] [6] [7] This variability has generated considerable interest in auto-CPAP home devices capable of continuously adjusting the pressure to the effective level. Theoretically, auto-CPAP does not require Peff titration or estimation. Moreover, comparisons of auto-CPAP devices with conventional constant-CPAP suggested similar efficacy. However, in some previous studies, auto-CPAP pressures were set to a narrow range above and below the Peff determined by a full polysomnography study or estimated by a formula. 8, 9 To our knowledge, only one study has previously reported a successful use of wide pressure range (4 to 14 cm H 2 O). 10 The aim of the present study was, as in previous studies, 8 -11 to conduct a prospective comparison of constant CPAP vs auto-CPAP, regarding patient tolerance, patient compliance, correction of nocturnal breathing disorders, improvements in sleep architecture, and relief from daytime sleepiness. The features of our study are as follows: (1) we sought to confirm that use of auto-CPAP with the same broad range of pressure variation (6 to 16 cm H 2 O) was possible in all patients; (2) constant CPAP and auto-CPAP were compared in the same patients using a crossover design; and (3) the patient follow-up was done at home to decrease costs and to avoid bias due to potential differences between in-laboratory polysomnography and daily conditions of CPAP use (for example, ingestion of alcohol or hypnotic agents).
Materials and Methods

Patients
This study was approved by the institutional review board of our institution, and written informed consent was obtained from each subject. We included patients in whom a clinical suspicion of OSAS was confirmed by a polysomnography study. Patients with restless legs, cardiac failure, cerebrovascular disease, or lung disease were excluded. Criteria for inclusion were as follows: (1) apnea/hypopnea index (AHI) Ͼ 10 events/h of sleep with obstructive events Ͼ 80% of total events, and (2) clinical indication for CPAP treatment according to American Thoracic Society recommendations. 12 Twenty-five consecutive patients who fulfilled these criteria gave their informed consent to participation in the study, conducted between November 1996 and December 1997. None of the patients had received auto-CPAP or constant CPAP before the study, and none of patients had undergone previous surgery for sleep apnea syndrome or snoring.
Sleep Recordings
Diagnostic polysomnography was done using an ambulatory device (Multi-Parameter analysis recorder 2/Medilog 9200; Oxford Medical Instrument; Abingdon, UK) that included EEG (C4-O1, C3-A2), electro-oculography, chin electromyography, electromyography of the tibialis anterior of both legs, oronasal thermistors, thoracic and abdominal movements by chest and abdominal impedance using ECG electrodes and adapters, and arterial pulse oximetry (Nellcor BS; Nellcor; Hayward, CA).
CPAP titration was performed in the sleep laboratory using a 14-channel paper recorder (Nihon Kohden; Tokyo, Japan) and included EEG (C4-O1, C3-A2), electro-oculography, chin electromyography, electromyography of the tibialis anterior of both legs, nasal flow measured using a Polysomnographic studies to check the efficacy of CPAP after each period of 2 months (see "Clinical Trial") were performed ambulatory using the same recording device as for diagnostic polysomnography (see above).
CPAP Characteristics
We used the "REM ϩ auto" apparatus (Nellcor Puritan-Bennett; Nancy, France), a CPAP device that can be set to either a constant CPAP or an auto-CPAP mode. A microprocessor-based monitor located inside the device provides natural-usage data.
In the automatic mode, this device ensures detection of apnea, hypopnea, and snoring. Because the inspiratory/expiratory pressure changes are automatically compensated for by instantaneous electronic pressure regulation, the corresponding changes in peak-to-peak pressure variations are used to estimate differences between maximal inspiratory and expiratory flow, and to detect the presence of apnea and hypopnea. To monitor patient breathing patterns, the REM ϩ auto (version 2.1) algorithm compares peak-to-peak pressure variations during the last breath vs the preceding eight breaths. If, for at least 10 s, flow is Ͻ 50% of the average value for the preceding eight breaths, hypopnea is detected and pressure is increased by 1 cm H 2 O. Apnea is defined as absence of breathing for Ն 10 s plus 62.5% of the mean breath time. Detection of apnea results in a 2-cm H 2 O pressure increase; if this fails to restore breathing, an additional 2-cm H 2 O pressure increase occurs once or, at the most, twice, with an interval of 15 s between each increase and the next.
Snoring was detected based on the occurrence of mask pressure vibrations. Mask pressure was measured using a highfrequency-response pressure transducer placed inside the REM ϩ auto device. The pressure signal was band-pass filtered (30 to 280 Hz), and its amplitude was analyzed using an automatic threshold system to detect amplitude variations. The pressure was increased by 1 cm H 2 O if two consecutive snoring breaths were detected. The algorithm of snoring detection was then disabled for 1 min, based on a previous study 13 in which snoring detection was disabled for 5 min. Whenever 10 min elapsed with no apnea, hypopnea, or snoring, airway pressure was reduced by 1 cm H 2 O.
Clinical Trial
At the beginning of the study, each patient underwent an ambulatory polysomnographic recording to confirm the presence of sleep-related breathing disorders. Daytime sleepiness was evaluated using the Epworth Sleepiness Scale. 14 A second polysomnography was done in the laboratory within 2 weeks to determine the Peff that abolished apnea, hypopnea, snoring, and sustained high-resistance inspiratory effort, defined as a flattened inspiratory flow signal with continuing esophageal pressure elevation. 15, 16 A randomized, crossover design was used. Patients received both CPAP modes for 2 months each. The order of the two treatments was allocated at random (2 months of constant CPAP followed by 2 months of auto-CPAP, or vice versa). The patients were not aware of the order of administration (ie, they were blinded to the setting mode until the first night of use, after which they could easily guess which mode they were using). The CPAP device was the same for the two CPAP modes, and patients were unaware of the presence of the microprocessor-based monitor placed inside the CPAP device to provide usage data.
The positive pressure used in the constant mode was the Peff. The pressure range used for auto-CPAP was the same in all patients: auto-CPAP was started at 6 cm H 2 O and was allowed to increase to not Ͼ 16 cm H 2 O, based on detection of snoring and/or apnea/hypopnea events, as described above. A lower pressure limit of 6 cm H 2 O was chosen based on previous studies of CO 2 rebreathing during CPAP and bilevel pressure ventilation, which have reported that rebreathing could occur when end-expiratory pressure was Ͻ 6 cm H 2 O. 17 A maximum allowed pressure of 16 cm H 2 O was chosen because higher pressures could worsen nocturnal breathing disorders by inducing periodic breathing and central apnea.
At the end of each 2-month period, the patients completed a questionnaire on OSAS symptoms, on their compliance with and tolerance to CPAP, as well as the Epworth Sleepiness Scale. 14 In addition, follow-up polysomnography was done, and data on CPAP use were collected.
The questionnaire on OSAS symptoms and CPAP tolerance (Table 1) was based on the complaints and comments frequently made by patients on home CPAP, and previously reported in the literature. 18 The items on OSAS symptoms and tolerance to CPAP were in two different sections of the questionnaire. Patients were asked to choose between six possible answers, scored 0 to 5, for each item in the first section: I do not know or I have never encountered this problem, very much decreased, decreased, unchanged, increased, and very much increased. Items in the second section could receive five answers, scored 0 to 4: I do not know or I have never encountered this problem, moderate, marked, very marked, and intolerable. The sums of the scores of the answers to the items in each section were calculated. The questionnaire was completed with the help of sleep laboratory technicians who were unaware of the CPAP mode.
The microprocessor located inside the CPAP device produced data on compliance in terms of effective duration of use (hours per night). The mean CPAP pressure was the Peff during the constant CPAP period and, during the auto-CPAP period, was calculated by the microprocessor over the entire observation period.
The two follow-up polysomnographic recordings were performed while using the CPAP apparatus in the same mode as during the previous 2 months, and was done at home to ensure that CPAP efficacy would be evaluated in conditions as similar as possible to those in real life. To summarize, four polysomnographic studies were done in total: the first to diagnose the sleep apnea syndrome (ambulatory), the second to establish the Peff (in laboratory), and the third and fourth were done to evaluate CPAP efficacy (ambulatory). The third polysomnography was done after the first 2-month treatment period. The fourth polysomnography was done after the next 2-month treatment period.
At the end of the 4-month study, the patients were interviewed by their physician and were told the results of the 2-month and 4-month polysomnography recordings,. The patients were then asked which of the two treatments they wished to use thereafter, given that both treatments were similarly effective in correcting OSAS and in improving sleep architecture. 
Data Analysis
Sleep staging was performed according to standard criteria. 19 EEG arousals were detected based on an abrupt shift in EEG frequency lasting Ͼ 3 s and Ͻ 15 s and including ␣-activity and/or frequencies Ͼ 16 Hz, except spindles. 19 ␣-Activity lasting Ͼ 15 s was considered to indicate awakening. The average number of awakenings and arousals per hour of sleep (awakening/arousal index; Ar/AwI) was calculated from the sum of the occurrences of both events.
An abnormal breathing event during sleep was defined according to commonly used clinical criteria as either complete cessation of airflow lasting at least 10 s (apnea) or at least a 50% decrease in airflow as compared to the previous breath and lasting at least 10 s (hypopnea). The absence of oxygen desaturation and/or EEG arousals did not eliminate hypopnea. In addition, detection of hypopnea by thermistor was double checked by analyzing the thoracic and abdominal movement signal, as the thermistor signal does not give fully accurate staging of hypopneic events. Hypopnea by the thermistor signal was confirmed by the detection of transient abnormalities in the thoracic and abdominal movement signal (either decreased signal or presence of paradoxical ventilation). Abnormal breathing events were classified as obstructive or central, according to whether respiratory effort continued or was correlated to the flow reduction. The average number of apneas and hypopneas per hour of sleep (the AHI) was calculated from the sum of sleep-disordered breathing events. Normal values used in our laboratory for both the AHI and Ar/AwI are Ͻ 10 events/h of sleep. 13 
Statistics
All numeric variables, such as anthropometric and sleep study data, are given as means Ϯ SD. Statistical significance of differences was tested with one-way analysis of variance (ANOVA) for repeated observations. When ANOVA was significant, paired t tests were used to make comparison between conditions. Correlation studies were performed using the z correlation test. The 2 test was used to compare percentages between two treatments for qualitative variables. Mean pressures used with constant CPAP and auto-CPAP were compared by paired t test.
In addition, a post hoc analysis was conducted for the duration of use regarding OSAS severity. Patient population was dichotomized in two groups on the basis of the baseline AHI, with a cutoff point of 60 events/h. The choice of the cutoff was based analysis on a receptor operator curve. Statistical significance of differences was tested with two-way ANOVA for repeated observations, using groups (AHI Ͻ 60 events/h, AHI Ն 60 events/h) and treatment (constant CPAP, auto-CPAP). All p values Ͻ 0.05 were considered significant. Statistical tests were performed using StatView 4.5 for Macintosh (Abacus Concepts; Berkeley, CA). 
Results
The 25 patients included 3 women and 22 men (mean age, 57 Ϯ 11 years; mean body mass index, 32 Ϯ 5 kg/m 2 ). Sleep architecture, severity of nocturnal breathing difficulties, and daytime sleepiness at baseline are shown in Table 2 . Normalization of AHI (Ͻ 10 events/h) was achieved in 18 patients with constant CPAP and in 15 patients with auto-CPAP (Fig 1) . Follow-up sleep studies showed that improvements in the AHI (Fig 1 and Table 2 ), Ar/AwI (Fig 2 and Table 2 ), sleep architecture, night oxygenation, and daytime sleepiness were similar with auto-CPAP and constant CPAP ( Table 2) .
The mean number of pressure changes during auto-CPAP was 4.7 Ϯ 2.6 events/h. Mean pressure was significantly lower when using auto-CPAP than constant CPAP (8.8 Ϯ 1.8 cm H 2 O vs 9.7 Ϯ 2.6 cm H 2 O, respectively; p ϭ 0.05; Fig 3) . However, a significant correlation was found between mean auto-CPAP pressure and Peff (r ϭ 0.64; p Ͻ 0.001). The order of administration of the treatment had no significant effect on mean pressure (p ϭ 0.59).
During the observation period, compliance with treatment in terms of hours of use per night did not differ across the two ventilation modes (constant CPAP, 4.7 Ϯ 1.8 h/night vs auto-CPAP, 4.1 Ϯ 1.8 h/night; p ϭ 0.20). A correlation was demonstrated between duration of constant CPAP use and duration of auto-CPAP use (r ϭ 0.62; p Ͻ 0.001). The order of administration of the treatments had no significant effect on compliance (p ϭ 0.95). CPAP use duration was Ն 4 h/night for 19 patients during the constant CPAP period vs 18 patients during the auto-CPAP period. Compliance was not correlated to mean pressure with either mode (p ϭ 0.39), nor was it correlated to diurnal somnolence evaluated by the Epworth Sleepiness Scale (p ϭ 0.17). A significant difference in CPAP-use duration emerged when patients were dichotomized based on OSAS severity as reflected by baseline AHI (Ͻ 60 events/h or Ն 60 events/h); this difference was independent from CPAP mode (Fig 4) . No differences were found in duration of use between auto-CPAP and constant CPAP in either OSAS severity group. Analysis of the questionnaire did not show a difference between the two modes in subjective improvement of OSAS symptoms (33 Ϯ 9 with constant CPAP vs 32 Ϯ 11 with auto-CPAP). The questionnaire on tolerance to CPAP showed no difference between the two modes (the score was for 26 Ϯ 7 for constant CPAP vs 30 Ϯ 11 for auto-CPAP. At the end of the observation period, the patients were asked to choose one of the two modes, after having been told that both modes were equally effective in correcting polysomnography abnormalities. Fifteen patients chose auto-CPAP and 8 patients chose constant CPAP; the remaining 2 patients requested surgical therapy because they were unable to tolerate either CPAP mode. The choice of mode was independent from the order of modes during the study period.
Discussion
The aim of this study was to conduct a randomized, crossover, at-home comparison of the efficacy of constant CPAP vs auto-CPAP in correcting nocturnal breathing disorders and attendant sleep architecture disruption and daytime sleepiness. We evaluated a strategy in which auto-CPAP could be used without using the data of a titration polysomnography study, namely by using the same wide pressure range in all patients, and not a pressure range set around the Peff. As previously reported, auto-CPAP and constant CPAP were equally effective in correcting sleep-disordered breathing and in improving sleep. Our study also demonstrated that auto-CPAP with a broad pressure range could be used effectively in all patients, suggesting that a previous titration night in the sleep laboratory could possibly be avoided.
Before discussing the implications of our findings, a number of methodologic issues need to be addressed. Although our patients showed marked improvements in sleep qualities and breathing abnormalities, 7 patients and 10 patients had an AHI Ͼ 10 events/h during constant CPAP and auto-CPAP, respectively (Fig 1) . Therefore, auto-CPAP and fixed constant CPAP were not as good as we would have liked and were less efficient than in some other studies. Indeed, previous studies, including one from our laboratory, 8 -10,13,16 demonstrated complete correction of OSAS by CPAP in most cases, with both constant CPAP and auto-CPAP. Nevertheless, the occurrence of hypopnea may have been overestimated in our study, since arousal or oxygen desaturation was not necessary for definite hypopnea, and hypopnea-associated desaturation can improve with CPAP. 20 This hypothesis is strengthened by the fact that (1) the Ar/AwI values obtained during CPAP and auto-CPAP in our study were similar to those obtained in other studies, 8 -10,13,16 and (2) that similar improvement in somnolence complaint, an important CPAP-efficacy criterion, was achieved with either mode. In addition, our patients had a higher AHI than in earlier studies, with a mean of 58 Ϯ 6 events/h and values Ͼ 70 events/h in some patients. It is worthy of note that previous studies in patients with AHI values Ͼ 70 events/h found results comparable to ours (ie, incomplete improvement in the most severely affected patients). 13, 21 Another important methodologic issue is that sleep recordings were performed at home, a setting in which factors likely to decrease treatment efficacy can occur, such as ingestion of hypnotic agents (theoretically absent from the sleep laboratory) or leaks at the mask (usually detected and corrected by sleep laboratory technicians).
Objective treatment compliance evaluated by the microprocessor located inside the device was surprisingly lower than in some studies. 8 -10,13,16 This discrepancy may stem from differences in the experimental design. First, the duration of use measured by the machine was the effective duration of use, and not only time counter analysis, which may account for a 30-min difference. Second, the auto-CPAP treatment was started at home and polysomnographic recordings were done at home. This last feature may have resulted in poorer compliance but offered the advantage of being closer to real-life situations. In addition, patients were totally unselected, consecutively enrolled patients. Last, to avoid bias, our patients did not benefit from close physician supervision, including home phone calls, which is usually offered and has been shown to improve patient compliance. 22 Nevertheless, compliance in our study was similar to that in a study 23 aimed at providing an objective measurement of patterns of CPAP use, and no difference was found between the two modes. No difference of compliance was found between auto-CPAP and constant CPAP, in contrast to other studies 10 and despite a statistically significant difference in mean pressure.
In agreement with previous results, 10 our results showed that auto-CPAP could be used without setting the pressure range around a Peff obtained by a prior titration night or estimated from anthropometric data. Thus, in addition to the classic indication for auto-CPAP, namely wide Peff variations in a given night or from night to night (eg, in OSAS occurring during a specific sleep stage such as rapid eye movement sleep), auto-CPAP set with a wide pressure range may be useful as a mean of obviating prior determination of the Peff. Furthermore, this method was not associated with decreased compliance. There is a theoretical possibility that CPAP use by a patient previously exposed to CPAP (during the titration night) or followed by mean of in-laboratory polysomnography may be different (possibly better) from CPAP use by a patient who is totally "naive" to CPAP. 24 However, this theoretical drawback of ambulatory follow-up can be overcome if needed, as compliance to treatment can be improved by very simple interventions. 22 In addition and in keeping with previous results, 25, 26 our study also demonstrated that OSAS can be effectively monitored by home studies.
In conclusion, we compared results of OSAS treatment by auto-CPAP vs conventional constant CPAP in the same patients using a crossover design. Our main findings are as follows: (1) auto-CPAP is as effective as constant CPAP in resolving sleep-related breathing disorders, nocturnal desaturation, and sleep fragmentation, and in improving daytime sleepiness; (2) compliance with nighttime treatment is the same with auto-CPAP and with constant CPAP, although patients are more likely to prefer auto-CPAP; and (3) wide pressure range can be used in all patients.
